<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel><title>Comments on: Neurofeedback For Autistic Spectrum Disorders: Promising Results In A Small Sample</title> <atom:link href="http://www.bmedreport.com/archives/339/feed" rel="self" type="application/rss+xml" /><link>http://www.bmedreport.com/archives/339</link> <description>health and wellness through psychological science</description> <lastBuildDate>Mon, 06 Sep 2010 13:47:01 -0500</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.0.1</generator> <item><title>By: cfisher</title><link>http://www.bmedreport.com/archives/339/comment-page-1#comment-18</link> <dc:creator>cfisher</dc:creator> <pubDate>Thu, 05 Feb 2009 21:10:33 +0000</pubDate> <guid isPermaLink="false">http://www.bmedreport.com/?p=339#comment-18</guid> <description>Posted on behalf of Mirjam Kouijzer (lead author of the research currently being discussed):Investigating effects of neurofeedback for autism spectrum disorders (ASD) is a relatively new field of research. Our first results were recently published in a paper that was reviewed by Christopher Fisher.Furthermore, a second paper investigating the long-term results of this treatment is now in press and expected soon. These positive results have given incentive for further studying the effects of neurofeedback in ASD. We are currently working on more extensive studies with larger samples to be able to draw more conclusions about the effects of neurofeedback for children with ASD and the working mechanisms that underlie these results. I am very happy to notice that neurofeedback is being discussed and of interest in a growing number of people. In order to be accepted as a full-fledged treatment next to behavioral therapy and medication, replications of the effects we found and additional studies with improved design to control for unspecific factors are needed.In addition to the summary that was given here, I would like to point to the results we found in the session data. This data comprises brain wave activity at the location where the electrode was placed during treatment, i.e. C4. At this location, participants were instructed to inhibit slow wave (theta) activity while enhancing faster brain waves (low beta or SMR) for 40 sessions. 65% of the participants showed a significant decrease in theta power and a significant increase in low beta power over 40 sessions. These data indicate that children with ASD are indeed able to act upon their brain wave activity. Interestingly, other studies examining effects of neurofeedback in other populations also point to 60-70% success rates.While reading Fisher’s comment I noticed some confusion about the protocol used in the study. As I mentioned before, treatment occurred at C4, that is, at the right hemisphere central location. The paper described electrode placement at C3 and C4, but feedback came only from C4. C3 was used only for monitoring brain wave activity over the left hemisphere. We found that neurofeedback training at C4 affects activation over both hemispheres. I hope this explanation clarifies the questions about the exact protocol that was used.Mirjam Kouijzer, Radboud University Nijmegen, the Netherlands</description> <content:encoded><![CDATA[<p>Posted on behalf of Mirjam Kouijzer (lead author of the research currently being discussed):</p><p>Investigating effects of neurofeedback for autism spectrum disorders (ASD) is a relatively new field of research. Our first results were recently published in a paper that was reviewed by Christopher Fisher.</p><p>Furthermore, a second paper investigating the long-term results of this treatment is now in press and expected soon. These positive results have given incentive for further studying the effects of neurofeedback in ASD. We are currently working on more extensive studies with larger samples to be able to draw more conclusions about the effects of neurofeedback for children with ASD and the working mechanisms that underlie these results. I am very happy to notice that neurofeedback is being discussed and of interest in a growing number of people. In order to be accepted as a full-fledged treatment next to behavioral therapy and medication, replications of the effects we found and additional studies with improved design to control for unspecific factors are needed.</p><p>In addition to the summary that was given here, I would like to point to the results we found in the session data. This data comprises brain wave activity at the location where the electrode was placed during treatment, i.e. C4. At this location, participants were instructed to inhibit slow wave (theta) activity while enhancing faster brain waves (low beta or SMR) for 40 sessions. 65% of the participants showed a significant decrease in theta power and a significant increase in low beta power over 40 sessions. These data indicate that children with ASD are indeed able to act upon their brain wave activity. Interestingly, other studies examining effects of neurofeedback in other populations also point to 60-70% success rates.</p><p>While reading Fisher’s comment I noticed some confusion about the protocol used in the study. As I mentioned before, treatment occurred at C4, that is, at the right hemisphere central location. The paper described electrode placement at C3 and C4, but feedback came only from C4. C3 was used only for monitoring brain wave activity over the left hemisphere. We found that neurofeedback training at C4 affects activation over both hemispheres. I hope this explanation clarifies the questions about the exact protocol that was used.</p><p>Mirjam Kouijzer, Radboud University Nijmegen, the Netherlands</p> ]]></content:encoded> </item> <item><title>By: cfisher</title><link>http://www.bmedreport.com/archives/339/comment-page-1#comment-12</link> <dc:creator>cfisher</dc:creator> <pubDate>Sat, 24 Jan 2009 14:42:46 +0000</pubDate> <guid isPermaLink="false">http://www.bmedreport.com/?p=339#comment-12</guid> <description>This is a technical discussion that may interest only neurotherapists. Others may have trouble following this discussion:The protocol used is somewhat unclear to me after a reread of this study. I do not believe now that a 2 channel protocol was used as I originally reported. The authors described electrodes placements at C3/C4 and A1, with A1 being a reference electrode.  There is no mention of a A2, which is typically required in a 2 channel hook up.  This means that C3 must have been a ground channel.  I have never used a 10/20 location as  ground location, but this does not mean that it cannot be done.  Thus, I believe that the researchers used a single channel protocol at C4.   I plan to contact them for elaboration. CFisher</description> <content:encoded><![CDATA[<p>This is a technical discussion that may interest only neurotherapists. Others may have trouble following this discussion:</p><p>The protocol used is somewhat unclear to me after a reread of this study. I do not believe now that a 2 channel protocol was used as I originally reported. The authors described electrodes placements at C3/C4 and A1, with A1 being a reference electrode.  There is no mention of a A2, which is typically required in a 2 channel hook up.  This means that C3 must have been a ground channel.  I have never used a 10/20 location as  ground location, but this does not mean that it cannot be done.  Thus, I believe that the researchers used a single channel protocol at C4.   I plan to contact them for elaboration. CFisher</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (enhanced)
Database Caching 1/6 queries in 0.024 seconds using disk
Object Caching 335/337 objects using disk
Content Delivery Network via cdn.bmedreport.netdna-cdn.com

Served from: www.bmedreport.com @ 2010-09-08 06:44:25 -->